About iSchemaView
iSchemaView, now operating as RapidAI, is a leading healthcare AI company specializing in advanced imaging solutions for life-threatening neurovascular, cardiac, and vascular conditions, with a primary focus on stroke. Their AI-powered platform, known as RAPID, analyzes medical images from CT and MRI scanners to provide physicians with rapid, accurate insights for diagnosis and treatment planning. This includes generating perfusion maps, identifying areas of reduced cerebral blood flow, and detecting conditions such as large vessel occlusion (LVO) and intracranial hemorrhage (ICH).
The RapidAI platform integrates seamlessly into hospital workflows, offering various modules like Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS, which assist in assessing salvageable brain tissue, identifying stroke patients eligible for thrombectomy, and managing cerebral aneurysms. The technology is clinically validated and has been instrumental in expanding stroke treatment guidelines globally, empowering clinicians to make faster, more informed decisions and ultimately improving patient outcomes across more than 2,200 hospitals in over 100 countries.
For physicians, RapidAI’s solutions are designed to complement clinical judgment, not replace it, by providing critical data and enhanced visualizations within minutes of a patient scan. This capability is crucial for time-sensitive conditions like stroke, where early and accurate diagnosis can significantly impact patient recovery and reduce disability. The platform also extends to other areas such as pulmonary embolism detection, demonstrating its versatility in clinical decision support.
Focus Areas
Business Intelligence
| Key Investors | Vista Credit Partners, Lennertz & Co., Sequoia Capital |
| Partnerships | Health Holdings Company, Siemens Healthineers, Ambra Health, Pulsara |
| Acquisitions | EndoVantage |
| Technology | AI-enabled software platform, deep learning, machine learning, expert feature extraction, cloud-native (Rapid Edge Cloud), DICOM compliant, AI Orchestrator, Navigator Pro, mobile app |
| FDA Clearances | 21 cleared products (estimated) |
What Physicians Need to Know
For physicians, iSchemaView (RapidAI) stands out by providing clinically validated, AI-powered solutions that deliver rapid, automated analysis of medical images (CT, CTA, CTP, MRI, MRA). This translates to faster and more accurate diagnoses, particularly in time-sensitive conditions like stroke and aneurysm, enabling quicker treatment decisions and potentially improved patient outcomes. The platform reduces cognitive burden by highlighting key findings and providing quantitative data, standardizes assessment (e.g., ASPECT scores), and offers advanced 3D visualizations. Its FDA-cleared tools are designed to complement, not replace, clinical judgment, acting as a '24/7 resident' to prioritize urgent cases and provide deeper clinical insights. The mobile access ensures critical information and team communication are available anytime, anywhere.
RapidAI's platform is built for seamless integration within existing healthcare IT infrastructure. It connects with Picture Archiving and Communication Systems (PACS), Electronic Health Records (EHR), worklists, and reporting systems. This ensures that AI-driven insights and results are automatically pushed into the radiologist's familiar workflow, reducing clicks and streamlining processes. Furthermore, the platform facilitates robust care coordination through secure mobile applications, desktop interfaces, and workstations, enabling real-time communication and image sharing among multidisciplinary care teams (ED, radiology, neurology, cardiology, intervention teams) across the entire health system.
What the Web Says
iSchemaView, known for its RapidAI platform, develops AI-enabled software for stroke and cerebrovascular imaging, assisting clinicians in diagnosis and treatment decisions. The company's products are used in over 500 stroke centers and have been instrumental in changing stroke treatment guidelines. While product reviews highlight the effectiveness and efficiency of RapidAI, employer reviews, though limited, suggest a positive startup culture with opportunities for growth.
Overall: PositiveStrengths
- RapidAI improves speed and accuracy of stroke diagnosis and treatment decisions.
- The platform provides automated, easy-to-interpret imaging for various stroke indications (e.g., MRI, CTP, CTA).
- RapidAI has been used in landmark stroke trials, influencing treatment guidelines.
- The software integrates with existing healthcare systems like PACS, email, and mobile devices for real-time notifications.
- Employer reviews mention an amazing startup experience and opportunities to wear multiple hats.
- The company's technology is considered cutting-edge in the field of AI medical diagnostics.
Limitations
- Limited evidence on the effects of RapidAI on some clinical outcomes such as patient harms, mortality, and cost-effectiveness.
- Ethical and equity considerations related to patient autonomy, privacy, transparency, access, and algorithmic bias need continuous monitoring.
- Some general concerns about AI in medical diagnostics regarding accuracy and potential for misinterpretation have been raised in broader discussions.
- Very limited public employee reviews make it difficult to form a comprehensive picture of the company culture.
Based on reviews from: Indeed.com, Canadian Journal of Health Technologies, accessdata.fda.gov, AuntMinnie, Tracxn, openPR.com, Canada's Drug Agency, NCBI Bookshelf, MDPI, Reddit, RapidAI.com
Last updated: 2026-07-18
Videos
News, demos, and interviews about iSchemaView.
Videos load interactively. If none appear, search YouTube for iSchemaView →
Press & Coverage
Frequently Asked Questions
Related Companies
Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]